Hong Kong · Delayed Price · Currency is HKD Republic Healthcare Statistics
Total Valuation
HKG:8357 has a market cap or net worth of HKD 69.26 million. The enterprise value is 50.23 million.
| Market Cap | 69.26M |
| Enterprise Value | 50.23M |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:8357 has 624.00 million shares outstanding. The number of shares has increased by 3.85% in one year.
| Current Share Class | 624.00M |
| Shares Outstanding | 624.00M |
| Shares Change (YoY) | +3.85% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 61.35% |
| Owned by Institutions (%) | n/a |
| Float | 241.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.33 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.43.
| Current Ratio | 3.12 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.09 |
| Interest Coverage | -19.19 |
Financial Efficiency
Return on equity (ROE) is -35.17% and return on invested capital (ROIC) is -69.14%.
| Return on Equity (ROE) | -35.17% |
| Return on Assets (ROA) | -15.74% |
| Return on Invested Capital (ROIC) | -69.14% |
| Return on Capital Employed (ROCE) | -31.73% |
| Weighted Average Cost of Capital (WACC) | 9.84% |
| Revenue Per Employee | 1.13M |
| Profits Per Employee | -446,671 |
| Employee Count | 46 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 14.07 |
Taxes
In the past 12 months, HKG:8357 has paid 101,177 in taxes.
| Income Tax | 101,177 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.49% in the last 52 weeks. The beta is 1.33, so HKG:8357's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -23.49% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 26.22 |
| Average Volume (20 Days) | 79,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:8357 had revenue of HKD 52.10 million and -20.55 million in losses. Loss per share was -0.03.
| Revenue | 52.10M |
| Gross Profit | 3.04M |
| Operating Income | -20.24M |
| Pretax Income | -20.45M |
| Net Income | -20.55M |
| EBITDA | -17.25M |
| EBIT | -20.24M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 39.78 million in cash and 20.75 million in debt, with a net cash position of 19.03 million or 0.03 per share.
| Cash & Cash Equivalents | 39.78M |
| Total Debt | 20.75M |
| Net Cash | 19.03M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 48.31M |
| Book Value Per Share | 0.08 |
| Working Capital | 30.18M |
Cash Flow
In the last 12 months, operating cash flow was -10.86 million and capital expenditures -8.12 million, giving a free cash flow of -18.97 million.
| Operating Cash Flow | -10.86M |
| Capital Expenditures | -8.12M |
| Depreciation & Amortization | 3.02M |
| Net Borrowing | -3.97M |
| Free Cash Flow | -18.97M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 5.83%, with operating and profit margins of -38.85% and -39.44%.
| Gross Margin | 5.83% |
| Operating Margin | -38.85% |
| Pretax Margin | -39.24% |
| Profit Margin | -39.44% |
| EBITDA Margin | -33.11% |
| EBIT Margin | -38.85% |
| FCF Margin | n/a |
Dividends & Yields
HKG:8357 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.85% |
| Shareholder Yield | -3.85% |
| Earnings Yield | -29.66% |
| FCF Yield | -27.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |